SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-053234
Filing Date
2018-10-10
Accepted
2018-10-10 16:43:29
Documents
7
Period of Report
2018-10-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv504599_8k.htm 8-K 28735
2 EXHIBIT 10.1 tv504599_ex10-1.htm EX-10.1 504152
3 EXHIBIT 10.2 tv504599_ex10-2.htm EX-10.2 72971
4 EXHIBIT 10.3 tv504599_ex10-3.htm EX-10.3 130646
5 EXHIBIT 10.4 tv504599_ex10-4.htm EX-10.4 34719
6 EXHIBIT 99.1 tv504599_ex99-1.htm EX-99.1 12258
7 GRAPHIC tv504599_ex99-1img1.jpg GRAPHIC 9535
  Complete submission text file 0001144204-18-053234.txt   798188
Mailing Address 1 BRIDGE PLAZA N, SUITE 270 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA N, SUITE 270 FORT LEE NJ 07024 201-464-2677
IMMUNE PHARMACEUTICALS INC (Filer) CIK: 0001208261 (see all company filings)

IRS No.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36602 | Film No.: 181116384
SIC: 2834 Pharmaceutical Preparations